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Abstract
Background: Obsessive-compulsive disorder (OCD), a severe mental disease manifested in time-consuming repetition
of behaviors, affects 1 to 3% of the human population. While highly heritable, complex genetics has hampered attempts
to elucidate OCD etiology. Dogs suffer from naturally occurring compulsive disorders that closely model human OCD,
manifested as an excessive repetition of normal canine behaviors that only partially responds to drug therapy. The
limited diversity within dog breeds makes identifying underlying genetic factors easier.
Results: We use genome-wide association of 87 Doberman Pinscher cases and 63 controls to identify genomic loci
associated with OCD and sequence these regions in 8 affected dogs from high-risk breeds and 8 breed-matched
controls. We find 119 variants in evolutionarily conserved sites that are specific to dogs with OCD. These case-only
variants are significantly more common in high OCD risk breeds compared to breeds with no known psychiatric
problems. Four genes, all with synaptic function, have the most case-only variation: neuronal cadherin (CDH2), catenin
alpha2 (CTNNA2), ataxin-1 (ATXN1), and plasma glutamate carboxypeptidase (PGCP). In the 2 Mb gene desert between
the cadherin genes CDH2 and DSC3, we find two different variants found only in dogs with OCD that disrupt the
same highly conserved regulatory element. These variants cause significant changes in gene expression in a human
neuroblastoma cell line, likely due to disrupted transcription factor binding.
Conclusions: The limited genetic diversity of dog breeds facilitates identification of genes, functional variants and
regulatory pathways underlying complex psychiatric disorders that are mechanistically similar in dogs and humans.
Background
Obsessive compulsive disorder (OCD) is a common (1 to
3% of the population) and debilitating neuropsychiatric dis-
order characterized by persistent intrusive thoughts and
time-consuming repetitive behaviors [1]. Twin studies show
OCD is very heritable (approximately 45 to 65% genetic in-
fluences for early onset OCD), but the underlying genetics
is complex [2,3]. More than 80 candidate gene studies of
OCD and a recent genome-wide association study (GWAS)
yielded no significant, replicable associations [4]. The most
strongly associated genes in the OCD GWAS implicate dis-
rupted glutamatergic neurotransmission and signaling in
disease pathogenesis [4].
A r t i f i c i a lm o u s em o d e l sh a v ep r o v e nm o r ee f f e c t i v ef o r
elucidating the neural pathways underlying OCD-like be-
haviors. Mice lacking Sapap3, which encodes a postsynaptic
scaffolding protein found at glutamatergic synapses, exhib-
ited excessive grooming and increased anxiety, symptoms
alleviated by treatment with selective serotonin reuptake
inhibitors, the same drug frequently used to treat OCD
patients [5]. Optogenetic stimulation of the orbitofrontal
cortex region affected by the Sapap3 mutation reversed de-
fective neural activity and suppressed compulsive behavior
[6]. Resequencing of exons of DLGAP3 (the human
SAPAP3 gene) revealed excessive rare non-synonymous var-
iants in human OCD and trichotillomania individuals [7].
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OCD that is genetically more complex than induced ani-
mal models [8]. Phenotypically, canine and human OCD
are remarkably similar. Canine compulsive disorder mani-
fests as repetition of normal canine behaviors such as
grooming (lick dermatitis), predatory behavior (tail chas-
ing) and suckling (flank and blanket sucking). Just as in
human patients, approximately 50% of dogs respond to
the treatment with selective serotonin reuptake inhibitors
or clomipramine [9]. Particular dog breeds (genetically
isolated populations) have exceptionally high rates of
OCD, including Doberman Pinschers (DPs), bull terriers
and German shepherds [10-12]. The high disease rates
and rather limited genetic diversity of dog breeds suggests
that OCD in these populations, while multi-genic, may be
less complex than in humans, facilitating genetic mapping
and functional testing of associated variants [13,14].
In an earlier GWAS of canine OCD, we associated
CDH2, a neural cadherin gene involved in synaptic plas-
ticity, with OCD in DPs [14]. Here, we use a more
powerful algorithm, MAGIC [15], to reanalyze the data
from this study and identify new OCD-associated re-
gions. These regions are enriched for genes involved
in synapse formation and function, as are regions with
patterns of reduced variation consistent with artificial
selection. We sequence the top candidate regions, 5.8 Mb
in total, and find that four genes, all with synaptic
function, are enriched for case-specific variants: neuronal-
cadherin (CDH2), catenin alpha2 (CTNNA2), ataxin-1
(ATXN1), and plasma glutamate carboxypeptidase (PGCP).
Furthermore, two intergenic mutations between the cad-
herin genes CDH2 and desmocollin 3 (DSC3) disrupt a
non-coding regulatory element and alter gene expression
in a human neuroblastoma cell line. Our results implicate
abnormal synapse formation and plasticity in OCD, and
point to disrupted expression of neural cadherin genes as
one possible cause.
Results
Genome-wide association studies and homozygosity
mapping
Using the raw data (included in Gene Expression Omnibus
accession numbers GSE53488 and GSE53577) from the
GWAS by Dr Dodman and collaborators [14], which in-
cluded 92 DP cases and 68 DP controls extensively pheno-
typed for canine OCD, we reanalyzed the Affymetrix
genotype intensity data with a new calling algorithm,
MAGIC [15]. MAGIC relaxes certain assumptions used in
other callers, such as Hardy-Weinberg equilibrium in
genotype clusters, to dramatically improve the accuracy of
genotypes called from Affymetix v2 Canine GeneChip
data. This yielded a 2.4-fold denser SNP map for
association mapping (55,651 SNPs; 35,941 SNPs with
minor allele frequency (MAF) >0.05) but a slightly
smaller sample size, with 87 cases and 63 controls
passing MAGIC quality filters (compared to our original
dataset of 14,700 SNPs with MAF>0.05 in 92 cases
and 68 controls; Figure 1a,b). The increased density
allowed us to identify 13 new candidate OCD-associated
regions (P<0.0001) in addition to the original chromo-
some 7 locus in CDH2 (Table S1 in Additional file 1). We
estimate that this dataset explains 0.56±0.18 of pheno-
type variance [16].
We tested all Gene Ontology (GO) gene sets with 5 to
1,000 genes (5,206 sets) for enrichment in the new GWAS
regions using INRICH, a permutation based software that
rigorously controls for region size, SNP density, and gene
size and gene number [17]. Overall, we observe an excess
of sets with P<0.01 (25 sets, P=0.03; Figure 1e). The top
set ‘GO:0045295 Gamma catenin binding’ is significant
even after stringent correction for the number of gene sets
tested (P=5.9×10
-5,P corrected=0.05) and includes genes
under each of three peaks of association spanning ap-
proximately 3 Mb on chromosome 7: CDH2, DSC3 and
DSG1 (Figure 1d,e; Table S2 in Additional file 1). The
GWAS regions also include two of 13 genes in
‘GO:0048814 Regulation of dendrite morphogenesis’ (P=
0.002): the calcium binding synaptogenesis gene SDC2
and the postsynaptic density protein gene TNIK,w h i c h
encodes a serine-threonine kinase involved in AMPA re-
ceptor trafficking and synaptic function [18,19].
The DP breed, like all dog breeds, was created through
population bottlenecks and artificial selection for mor-
phological and behavioral traits, potentially driving some
OCD risk alleles to very high frequency and thus un-
detectable by GWAS. Consistent with this hypothesis,
we find functional connections between associated genes
and genes in the 13 largest autosomal regions of fixation
in the DP breed (25.7 Mb in total; Table S3 in Additional
file 1). For example, the tyrosine kinase FER mediates
cross-talk between CDH2 and integrins [20], and deple-
tion of presynaptic FER inhibits synaptic formation
and transmission [21]. CTNNA2 interacts with CDH2 to
regulate the stability of synaptic cell junctions [22].
While most fixed regions contain many genes, making it
difficult to identify top candidates, several contain just
one gene, including the neuronal protein gene LINGO2
and the synaptic-2 like glycoprotein gene TECRL.
We also identified 128 regions of unusually low vari-
ability in the DP breed compared to 24 other dog breeds
(23.73 Mb; Table S4 in Additional file 1) [23]. When we
test these regions of reduced variability (RRVs) for gene
set enrichment in the entire GO catalog, as described
above, 10 GO terms are more enriched in DP RRVs
than any other breed (Figure 1f). Half of these have
clear relevance to brain function, including regulation
of neurotransmitters, neural projection, and dendrite
morphogenesis. We also see enrichment for mannose
Tang et al. Genome Biology 2014, 15:R25 Page 2 of 14
http://genomebiology.com/2014/15/3/R25c
f
e
d
a
b
Figure 1 (See legend on next page.)
Tang et al. Genome Biology 2014, 15:R25 Page 3 of 14
http://genomebiology.com/2014/15/3/R25binding-related genes, echoing the strong enrichment in
GWAS regions for alpha-mannosidase activity. Mannose
structures are concentrated at excitatory synapses, in-
cluding glutamate receptors [24,25].
Targeted sequencing
We designed a sequencing array (Tables S5 and S6 in
Additional file 1) that targeted nine of the top GWAS
regions, including the CDH2 locus (3.9 Mb; Figure S1 in
Additional file 1) as well as genes and conserved ele-
ments within the five largest DP fixed regions (Table S3
in Additional file 1). We focused on fixed regions (total-
ing 1.8 Mb) that were also fixed in two other OCD af-
fected breeds, German shepherds (LUPA reference panel
[26]) and bull terriers (20 dogs) (Figure 1c). We se-
quenced eight cases and eight matched controls from
breeds at high risk for OCD, including eight DP, four
German shepherds, two Shetland sheepdogs and two
Jack Russell terriers (Figure 2a). We selected DPs based
on their genotype for the CDH2 risk haplotype [14] (two
homozygous cases, two heterozygous cases, and four
controls without the risk haplotype). We captured 92%
of the target regions at >20× coverage, with 76× mean
read depth coverage per sample (Table S7 in Additional
file 1). In total, we detected 24,930 high-quality SNPs,
7,645 short INDELs, and 173 deletions, with high con-
cordance to the SNP array data (median 99.5% for ap-
proximately 390 SNPs tested per sample; Table S8 in
Additional file 1).
Case-only variant discovery from sequence data
With our small sample size (eight cases and eight con-
trols from four different breeds), we did not expect to
have sufficient power to detect statistically significant al-
lelic associations with OCD. Instead, we focused on vari-
ants seen only in OCD cases (‘case-only variants’) as the
strongest causal candidates. Of 32,575 variants, 2,291
variants are case-only (2,002 SNPs and 289 INDELs; 80
to 966 per dog), while 3,116 variants are specific to con-
trol dogs (‘control-only variants’; 2,698 SNPs and 418
INDELs; 156 to 1,476 per dog) (Table 1; Table S9 in
Additional file 1). While there is no significant difference
between the total number of case- and control-only vari-
ants (Wilcoxon test P =0.63; Figure 2b), case dogs have
a significantly greater number in evolutionarily con-
strained elements (median 15 versus 4, Wilcoxon test
P =0.02; Materials and methods; Figure 2b; Table S9
in Additional file 1). Excluding coding variants increases
the difference further (median 15 versus 3, Wilcoxon
test P =0.01), suggesting that the excess of case-only
functional variants may be due largely to noncoding
variation.
Genotyping case-only variants in independent samples
We genotyped 114 case-only, evolutionarily constrained
variants in an independent set of dogs from breeds with
high rates of OCD (‘OCD-risk breeds’; 69 dogs) and
breeds with normal rates of OCD and other psychiatric
disorders (‘control breeds’; 19 dogs). Except for 14 cases
from OCD-risk breeds, we have no individual OCD
phenotype information for these dogs (Figure 2a). We find
that the case-only variants identified in the sequence data
are significantly more common in OCD-risk breeds, with
median frequency (FOCD) of 0.17, than in control breeds,
where the median frequency (Fcontrol)i s0 . 0 5( W i l c o x o n
test P=0.045; Table S10 in Additional file 1). The median
frequency increases to 0.20 when only phenotyped cases
are considered (Wilcoxon test P=0.015, comparison
with Fcontrol). We also observe an inverse correlation be-
tween the frequency difference between OCD-risk and
control breeds and the frequency across all genotyped
dogs (Pearson’sR=−0.63, P=8. 4×10
-14;F i g u r e2 c ) .T h u s ,
the variants most enriched in OCD-risk breeds are other-
wise rare, potentially due to either positive selective pres-
sure in OCD-risk breeds or negative selection in the
control breeds. While this suggests an association with
OCD, we note that other traits may also systematically dif-
fer between the two breed groups.
Gene-based analysis
We identified genes enriched with case-only variants
using a gene-based analysis method that accounts for
multiple independent variants within a gene and greatly
increases power for identifying disease-associated genes
[28]. Four genes have an excess of case-only variation
in evolutionarily constrained elements, even after cor-
recting for gene size: ATXN1, CDH2, CTNNA2, and
PGCP (10, 16, 12, and 16 case-only variants, respectively;
(See figure on previous page.)
Figure 1 Associated and fixed regions in Doberman Pinschers are enriched for brain-related pathways. (a) The original GWAS dataset
showed a single peak of association at CDH2 [14]. (b) Recalling with MAGIC yielded a 2.4-fold denser SNP dataset and allowed us to define 17
distinct regions of association with P<0.0001 using linkage disequilibrium (LD) clumping (Figure S1 in Additional file 1), a subset of which were
targeted for sequencing (red dots, genes labeled above peak). (c) In four breeds with high rates of OCD, we identified regions of fixation (black
boxes), a subset of which we targeted for sequencing (red boxes). Sequenced regions were selected because they were large and overlapping
between breeds (Table S1 in Additional file 1). (d) LD clumping identified three distinct regions of association on chromosome 7 (boxes, with
targeted regions in red). (e) The top Gene Ontology gene sets enriched in the GWAS regions. (f) GO gene sets enriched in Doberman Pinscher
regions of reduced variability (RRVs) but not in 24 other breeds (grey circles, most at 0).
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Because the sequenced DPs were selected based on
their haplotype at CDH2, we confirmed that the case-
only enrichment at CDH2 persists even when DPs are
excluded (Figure 3b). RNA-Seq data show all four genes
are expressed in the dog brain (KL-T, unpublished
observations).
Three of the four candidate genes, CDH2, PGCP and
ATXN1, are associated with OCD in the DP GWAS
study (chr7:63867472, P =2.1×10
-5; chr29:44152594,
P =1.5× 10
-5; chr35:18565131, P =1.6 ×10
-5, respect-
ively), while the fourth, CTNNA2, falls in a large region
of fixation (900 kb) in the DP breed (Figure 3c). In our
genotyping dataset, the case-only variants in these four
genes are more common in OCD-risk breeds (FOCD =
0.08 versus Fcontrol= 0.026, Wilcoxon test P =2.95 ×10
-4;
Figure 3d), particularly in CDH2 (FOCD =0.23 versus
Fcontrol= 0.027, P= 0.001) and in PGCP (FOCD= 0.014
versus Fcontrol =0.0, P= 0.047). We see a similar, though
weaker, pattern in ATXN1 (FOCD =0.022 versus Fcontrol =
0.0, P =0.3) and CTNNA2 (FOCD =0.185 versus Fcontrol =
0.026, P =0.13). In CTNNA2, the difference is clearer
(P =0.054) if only variants with frequency <0.20 are
considered.
Of the 40 variants genotyped in these four genes,
seven overlap chromatin marks, potentially indicating
regulatory function. Four variants in CDH2 overlap
H3K27Ac histone marks and/or DNase1 hypersensitivity
clusters. Three of these (chr7:63845160, chr7:63852056,
and chr7:63832008) are observed in OCD-risk breeds, at
frequencies of 0.435, 0.050, and 0.022, respectively, and
never seen in control breeds. The fourth variant
(chr7:63806661) is four-fold more common in OCD-risk
breeds (frequency =0.11 versus 0.026 in control breeds).
Three variants in ATXN1 alter regions transcribed in the
dog brain (KL-T, unpublished RNA-Seq data), including
a putative enhancer variant not seen in the control
breeds (chr35:18850625, OCD-risk breed frequency =
0.014). These variants, which lie in genes enriched for
case-only variants, are overrepresented in cases, and
alter putative regulatory elements, are strong candidates
for further functional elucidation.
Single variant analysis
We next sought to identify the top candidate functional
variants in the sequencing data. We first looked for coding
variants found exclusively in cases. Most were missense
mutations disrupting genes with little known relevance to
brain functions (Table S12 and Text S2 in Additional file 1).
More intriguing, one of our two Jack Russell terrier cases
has a 1.2 kb deletion (chr29:44178339–44179516; Figure S2
in Additional file 1) overlapping exon 2 of the gene PGCP,
causing a frameshift and loss of 70 amino acids from
the protein. PGCP is one of the four genes enriched
for case-only variants, and, while none of the DP
cases has this particular deletion, a nearby SNP is
(See figure on previous page.)
Figure 2 Targeted sequencing identifies case-only variants that alter constrained elements and are more common in high OCD risk
breeds. (a) We performed targeted sequencing of a small number of cases and controls from four breeds (row 1) and subsequently genotyped
the top candidate variants in a larger panel of dogs from those four breeds as well as two more high ‘OCD-risk’ breeds and two low risk ‘control
breeds’ (row 2). (b) Across all variants identified in the sequencing data, the number of case-only (orange box) and control-only (purple box)
variants is similar, but constrained elements are enriched for case-only variants. Boxes mark the 25th to 75th percentile across dogs, with the
median shown as a thick line, and whiskers extending to values within 1.5 times the difference between the 25th to 75th percentiles. Outliers are
marked with circles. (c) Case-only variants have higher frequency in OCD-risk breeds and lower frequency across all genotyped breeds. The x-axis
represents allele frequencies across all genotyped dogs. The y-axis represents normalized allele frequency (AF) differences between OCD-risk and
control breeds ([AFOCD-risk -A F control]/[AFOCD-risk+A F control]). The straight downward line represents the linear model for the data points. The blue
shade shows the 95% confidence interval for this model. Area under the curve (shaded in grey) is notably larger in AFOCD-risk>AF control than in
AFOCD-risk <AF control, showing that case-only variants are more common in OCD-risk breeds than in control breeds.
Table 1 Sequence variants identified by targeted resequencing of 5.8 Mb in eight cases and eight controls
Annotations All 16 dogs Variants in cases Variants in controls Case-only variants Control-only variants
All variants 32,575 29,425 30,253 2,291 3,116
Missense mutations 71 64 61 6 7
Nonsense mutations 0 0 0 0 0
Frame-shift mutations 2 3 3 0 0
Silent coding variants 108 97 89 18 11
UTR variants 22 16 22 0 6
Essential splice site 1 1 1 0 0
Conserved sites
a 1,024 930 908 119 91
aConserved sites determined by 29 mammals sequence data set [27].
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http://genomebiology.com/2014/15/3/R25Figure 3 Gene-based analysis identifies four top genes enriched for case-only variants in constrained regions. (a) Genes are plotted
according to the number of case-only (y-axis) and control-only (x-axis) variants within a gene and its 5 kb flanking regions from our sequence
data. Blue squares denote all the variants and the corresponding axes are shown in blue; red diamonds denote variants in constrained elements
only and the corresponding axes are shown in red. Genes that are plotted above the identity line harbor more case-only than control-only
variants. (b) A similar analysis excluding DP, the breed used to identify genes for sequencing, shows that the enrichment pattern persists for several
genes. (c) The case-only variants in constrained elements, when plotted with gene structure and evolutionary conservation, show clustering in ATXN1
(5’ end). Dimmed bars represent canine variants that failed to lift over onto hg19. The conservation track shows a measure of evolutionary conservation
in dog, human, mouse and rat [29]. (d) In each gene, SNPs with the greatest risk allele frequency (AF) difference between OCD-risk and control breeds
(y-axis) tend to have lower frequency across all genotyped breeds (y-axis). SNPs are shown as solid circles with vertical lines.
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(chr29:44152594, P =1 .5×1 0
-5;F i g u r e1 ;F i g u r eS 3i n
Additional file 1). Using quantitative PCR (qPCR), we
validated the deletion in the Jack Russell terrier cases
and tested 74 dogs from OCD-risk breeds (including
10 unphenotyped Jack Russell terriers and 14 dogs
from several breeds diagnosed with OCD) and 20 dogs
from control breeds. We found the deletion in three
Jack Russell terriers and in one Welsh terrier with
OCD, and in none of the control breed dogs, suggest-
ing it is associated with increased risk of OCD in mul-
tiple breeds.
We next looked for non-coding variants seen only
in cases, focusing on 15 seen in more than one DP
case. All but two are near the GWAS peak in intron 2
of CDH2 (chr7:63867472, P= 2.1×10
-5), reflecting the
selection of DP dogs for sequencing based on their
genotype at this locus. None of the 13 is obviously func-
tional based on evolutionary constraint and histone
marks. The other two variants are more interesting,
changing a conserved region approximately 172 kb
away from an associated GWAS SNP (chr7:61865715,
P =1.6× 10
-5), in the gene desert between the cadherin
genes CDH2 and DSC3 (Figure 4a). The first SNP
(chr7:61693835, T changed to C; SNP35 T >C) is exclu-
sively found in three of four sequenced DP cases and
showed the overall DP breed frequency of approximately
0.30 in our genotyping data set. The second SNP, a pri-
vate variant in the fourth DP case (chr7:61693855;
SNP55 A >T), is just 20 bases away and alters the same
highly conserved region (Figure 4b,c).
Functional assessment of candidate variants
Because the region altered by SNP35 and SNP55 showed
evidence of regulatory function (Figure 4b), we tested
whether the risk alleles disrupt gene expression using
a luciferase reporter assay. Including the wild-type
region in the reporter construct lowers expression 14-
to 20-fold in human neuroblastoma SK-N-BE(2) cells
(vector versus wild type, t-test Bonferroni corrected
P =3.5× 10
-7; negative control versus wild type, t-test
Bonferroni corrected P =2.9× 10
-7; Figure 4d). Adding
the SNP55 risk variant to the construct, however,
significantly increases expression relative to the wild-
type version, suggesting the regulatory element no lon-
ger functions normally (1.6-fold change, paired t-test
Bonferroni corrected P=1. 1×10
-4; Figure 4d). Curiously,
the SNP35 risk allele has the opposite effect, repressing
expression even further (0.9-fold change, paired t-test
Bonferroni corrected P=3.7×10
-3; Figure 4d).
Using an electrophoretic mobility shift assay (EMSA)
to examine DNA protein binding in the region, we see
that, while the SNP55 risk allele causes no apparent
change relative to wild-type, the SNP35 risk allele shows
markedly reduced binding (Figure 4e). Three transcrip-
tion factors are predicted by TRANSFAC [32] to bind the
wild-type sequence but not the SNP35 variant (PRRX2,
Oct-1 and Nobox; Figure S4 in Additional file 1). How-
ever, we saw no evidence that these three proteins bind
the region in a supershift assay (Figure S5 in Additional
file 1), suggesting other factors are critical. More than 90
transcription factors are predicted to bind the wild-type
sequence using various discovery tools [33]. Thus, both
SNP35 and SNP55 significantly change the silencing activ-
ity of the regulatory element, but in opposite directions
and possibly through different mechanisms.
Discussion
Through a small GWAS (fewer than 90 cases and 70
controls) we identified OCD-associated loci, which, par-
ticularly when analyzed together with regions of low
variability, implicate specific cellular pathways in disease
etiology. We sequenced nine of the top regions of asso-
ciation and five regions of fixation in eight OCD cases
and eight breed-matched controls. We found a notable
excess of case-only variation in evolutionarily conserved
regions, particularly in non-coding elements with poten-
tial regulatory function. This suggests noncoding vari-
ation is a major factor in canine OCD similar to human
neuropsychiatric diseases, and unlike most artificially in-
duced mouse models. While the dog population is com-
posed of >400 genetically isolated breed populations,
just a small number of breeds are highly enriched for
OCD, suggesting that OCD risk variants are more preva-
lent in these breeds. We show that the case-only variants
found in the sequence data are in fact significantly more
common in OCD-risk breeds compared to breeds with
no increased risk of psychiatric disorders.
By comparing the sequence data using gene-based tests,
we confirmed one gene (CDH2) and identified three novel
ones (CTNNA2, ATXN1,a n dPGCP) strongly implicated
for involvement in disease.
CDH2, a neural cadherin, encodes a calcium dependent
cell-cell adhesion glycoprotein important for synapse as-
sembly, where it mediates presynaptic to postsynaptic ad-
hesions [34]. Disrupting expression of CDH2 in cultured
mouse neurons causes synapse dysfunction, synapse elim-
ination and axon retraction [35].
CTNNA2 encodes a neuronal-specific catenin protein
that links cadherins to the cytoskeleton [34,36] and is
associated with bipolar disorder [37], schizophrenia
[38], attention deficit hyperactivity disorder [38] and
excitement-seeking [39]. Mice with a deletion of CTNNA2
showed disrupted brain morphology and impaired startle
modulation [40]. Cadherin-catenin complexes play a pivotal
role in synapse formation and synaptic plasticity and
therefore may be involved in the process of learning
and memory [41].
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ulates the Notch pathway [42], a developmental pathway
also active in the adult brain, where it mediates neuronal
migration, morphology and synaptic plasticity [43]. Mice
with a deletion of ATXN1 showed pronounced deficits
in learning and memory [44].
C D H 2 ,C T N N A 2a n dA T X N 1h a v es i m i l a rs p a t i a l
expression patterns in the brain and are important
during brain development and for synaptic plasticity.
CDH2 and CTNNA2 are highly expressed in the pre-
frontal cortex, amygdala, thalamus and fetal brain
[34,45]. ATXN1 is highly expressed in the prefrontal
Figure 4 Two intergenic case-only variants disrupt a repressor element and change gene expression in vitro. (a) The two case-only
variants are just 20 bases apart in a 2.5 Mb gene desert between DSC3 and CDH2 on canine chromosome 7. (b) The syntenic region of human
chromosome 18 shows markers of DNase hypersensitivity, transcription factor binding, repressor binding, histone methylation [30], and
mammalian constraint [31]. (c) Both variants, SNP55 and SNP35, alter bases that are highly constrained across mammals, SNP55 to an A and
SNP35 to a T. Compositions of the four bases for each position in the 29 mammals comparison [27] are shown with different grey scale and
height of bars (the higher the more conserved in multiple species). (d) The wild-type regulatory sequence represses luciferase reporter expression
in SK-N-BE(2) neuroblastoma cells. Both variants significantly change the extent of repression relative to wild type, with SNP35-G more repressive
and SNP55-A less repressive. The firefly luciferase expression in the test plasmids were normalized against the co-transfected Renilla luciferase
expression in pGL4.73. The P-value of the significance of the change relative to wild type is shown above each bar, with vertical lines showing
standard error of the mean. (e) An electrophoretic mobility shift assay testing the wild-type alleles (lanes 1 to 4) and the OCD-risk alleles (lanes 5
to 8) of SNP35 (top gel) and SNP55 (bottom gel) show that nuclear protein binding (red arrow) to the SNP35 locus is disrupted by the risk allele.
Nuclear extract was derived from SK-N-BE(2) cells. We used a 200-fold molar excess of competitor where appropriate.
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[45,46].
Intriguingly, the three genes appear to have functional
connections to the top SNPs (association P <10
-5)i na
recent human OCD GWAS, which found no single asso-
ciations reaching genome-wide significance, but impli-
cated glutamatergic signaling pathways [4] (Figure S6 in
Additional file 1). Most notably, one of the top associ-
ated genes in human patients, GRIK2, encodes a glutam-
ate receptor recruited to the synaptic membrane by
CDH2/catenin complexes [47] and another top candi-
date, PKP2, mediates CDH2 cell adhesion and desmo-
somal junctions [48]. In addition, several genes whose
expression levels correlate with the top human OCD-
associated SNPs interact with the genes we identify in
dogs: LRSAM1 (cerebellum) and NARS (frontal lobe)
interact with ATXN1; SPAG9 (cerebellum) acts in develop-
mental pathways with CDH2 and CTNNA2 [49].
The fourth gene, PGCP, encodes a poorly characterized
plasma glutamate carboxypeptidase. It may help hydrolyze
N-acetylaspartylglutamate (NAAG), the third most abun-
dant neurotransmitter in the brain, to glutamate and
N-acetylaspartate (NAA) [34], suggesting a potential role
in glutamatergic synapse dysfunction. PGCP is associated
with migraine [50], which is frequently co-morbid with
OCD [51].
We hypothesize that CDH2, CTNNA2, ATXN1, and
PGCP may work in concert to regulate glutamatergic
synapse formation and function in the cortico-striatal-
thalamo-cortical (CSTC) brain circuit previously impli-
cated in the pathogenesis of OCD [52-56].
Single variant analysis corroborates our hypothesis of
dysregulated synapse formation in OCD. All four se-
quenced DP cases had one of two mutations (SNP35
and SNP55) in a regulatory region, between DSC3 and
CDH2, that we show acts as a strong silencer. The
OCD-risk allele of SNP55 significantly increased the re-
porter gene expression while the OCD-risk allele of
SNP35 had the opposite effect. While surprising, other
studies have shown that either deletion or reciprocal
duplication of loci such as 17p11.2 and 15q13.3 can
cause neuropsychiatric disorders [57]. For SNP35, we
confirmed using EMSA that the OCD-risk allele changes
DNA binding. We saw no change at SNP55, although
in vitro assays may not capture all relevant in vivo reac-
tions. The regulatory element is between CDH2 (2.2 Mb
away) and DSC3 (0.3 Mb away), both cadherin genes
involved in gamma-catenin binding (Figure 1d,e), sug-
gesting disrupted gamma-catenin binding may be an
important risk factor for OCD. Additional sequence
data from DSC3 (not included in the current targeted
sequencing design) and more functional analysis are
needed to understand the two SNPs’ effects on CDH2
and DSC3.
Conclusions
Modeling neuropsychiatric disorders in animals is compli-
cated by both limited understanding of the underlying
neurobiology and subjective diagnostic criteria [58]. Natu-
rally occurring canine compulsive disorder is a remarkably
good model for human disease, as it is equivalent by most
clinical metrics, including age of onset, symptoms, and
pharmacological response. The work we present here sug-
gests similar genetic etiology as well. We harness the lim-
ited genetic diversity of dog breeds, and high rates of OCD
in particular breeds, to identify genes, pathways and non-
coding candidate functional variants. Dogs suffer from a
wide range of psychiatric disorders and have been strongly
selected for a variety of behavioral traits, making them a
uniquely powerful natural model organism for investigating
inherited psychiatric diseases in humans.
Materials and methods
GWAS and sequencing region selection
The GWAS using the sample set and phenotypes pub-
lished previously [14] was rerun using genotypes called
with the new MAGIC algorithm [15]. Briefly, MAGIC
(Multidimensional Analysis for Genotype Intensity Clus-
tering) does not use prior information to make genotype
calls (that is, cluster locations Hardy-Weinberg equilib-
rium, or complex normalization of probe intensities). In-
stead, it performs quantile normalization of the data for
each chip independently followed by a principal compo-
nent analysis of all chips on a SNP-by-SNP basis, neatly
summarizing the raw data.
The processed data are then clustered into genotype
calls through expectation maximization using a t-
distribution mixture model. Association was calculated
with a standard chi-squared test in PLINK [59] (SNP
genotype rate >90%, individual genotype rate >25%,
MAF >5%) and regions were defined with linkage disequi-
librium -based clumping around SNPs with P<0. 00 01
(that is, SNPs within 1 Mb with r
2>0.8 and P<0. 01 )
(Table S1 and Figure S1 in Additional file 1). We identified
regions of fixation as regions of >1,000 kb with more than
five SNPs and >95% SNPs with MAF <0.05 and selected a
subset found in breeds prone to OCD for targeted sequen-
cing. From the associated and fixed regions we designed a
5.8 Mb targeted sequencing array that optimized inclusion
of potential genes of interest within the design limitations
(Tables S5 and S6 in Additional file 1).
Gene set enrichment analysis
We expanded the GWAS regions to include all genes
within 500 kb of the original region start or end (Table
S1 in Additional file 1). We defined RRVs by comparing
the DP breed to 24 other dog breeds from a published
reference dataset and identifying the 1% least variable
150 kb regions in DP [23]. We ran INRICH with
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any gene sets from the GO catalog. We tested all gene
sets with between 5 and 1,000 genes (downloaded from
the Gene Ontology website on 18 May 2013) [17]. We
used a map file of 16,433 genes lifted over to canFam2.0
from the hg19 RefSeq Gene catalog (UCSC Genome
Brower, single match using default parameters) [60]. To
identify gene sets with unusually high enrichment in the
DP RRVs, we calculated, for all sets with P <0.05 and at
least 2 RRV genes in DP, the average difference in en-
richment P-values between DP and 24 other breeds [26]
(Figure 1f).
Sequenced samples
The targeted sequencing experiment comprised a total
of eight cases and eight controls from multiple breeds:
DP (four cases + four controls), German shepherd (two
cases + two controls), Jack Russell terrier (one case + one
control) and Shetland sheepdog (one case + one control)
(Figure 2a). The four DP cases supplied by Dr. Meurs
showed flank sucking behavior, while the German
Shepherd, Jack Russell terrier and Shetland sheepdog
cases were tail-chasers.
Targeted sequencing and variant calling
The 16 samples were individually barcoded and the
targeted regions were captured by a NimbleGen
Sequence Capture 385 K Array according to the man-
ufacturer’s protocol. The captured samples were then
pooled and sequenced on an Illumina Genome
Analyzer II. Paired-end 76-bp reads were aligned to
canFam2.0 and PCR duplicates were removed using
Picard [61], and realignment and recalibration were
processed through Genome Analysis Toolkit (GATK)
[62,63]. SNPs and small INDELs were identified using
GATK. We only considered the variants that pass the
GATK standard filters. Larger structural variants were
detected by GenomeSTRiP [64]. We manually checked
the alignments of all discovered deletion sites for
aberrant read pairs and read depth using Integrative
Genomics Viewer [65] to ensure the reliability of the
calls. We excluded a Shetland sheepdog pair where the
control had lower SNP accuracy, when comparing case-
and control-only variant counts (Figure 2b and Table S9
in Additional file 1).
Genotyping candidate sequence variants
We first selected case-specific variants that were within
evolutionarily constrained elements determined by a 29
mammals sequence dataset [27]. We then selected a
subset of the variants meeting one of the following cri-
teria: (i) case-only variants within DP breed; (ii) case-
only variants within CDH2, PGCP, CTNNA2 and ATXN1
that are identified by gene-based analysis; (iii) case-only
variants across at least two breeds; (iv) potential func-
tional variants annotated as nonsense, splicing or mis-
sense (predicted to be ‘probably’ or ‘possibly damaging’
by Polyphen-2 [66]) and case-only variants in at least
one breed; (v) variants within CDH2 risk haplotype; and
(vi) top associated variants from GWAS analysis. Of
140 variants that met one of the criteria, 127 variants
passed Sequenom design standards, and were geno-
typed using the Sequenom iPlex system. We employed
an independent set of 94 dogs that consisted of 10
dogs without obvious health problems for each of 6
OCD-risk breeds (that is, 4 sequenced breeds and
West Highland white terrier (Westie) and bull terrier
(bull terrier)) and two control breeds without known
psychiatric problems (greyhound and Leonberger), and
14 additional OCD cases from various breeds (2 bull
terrier, 2 DP, 1 German shepherd, 1 Westie, 1 Golden re-
triever, 1 Irish wolfhound, 1 pug, 1 Shiba, 1 Shepherd mix,
1 standard poodle, 1 Shih Tzu, 1 Welsh terrier). Geno-
type data were cleaned by removing samples with
missing genotype rates >10% and excluding SNPs
with call rates <90%. After the quality control, 114
SNPs and 88 dogs (19 (10 Leonbergers +9 Greyhounds)
from control breeds and 69 (14 cases +5 DP+10 bull
terrier+10 Westie+10 German shepherd+10 Shetland
sheepdogs+10 Jack Russell terriers) from OCD-risk
breeds or cases) were retained in our analysis (Figure 2a;
Table S10 in Additional file 1).
Gene-based analysis
Each gene region was defined using the coordinates from
RefSeq hg19 lifted over to canFam2.0 plus 5 kb flanking
sequence on each side. We counted the number of case-
and control-only variants and compared the counts for
each gene. Genes that have excessive case-only variants
relative to control-only variants were considered as poten-
tial risk genes for OCD. The same analysis was applied to
the variants within constrained elements. To correct for
gene size, we calculated the ratio of the number of case-
only variants and the number of control-only variants for
each gene additionally.
Electrophoretic mobility shift assay
For each allele of the tested SNPs in a regulatory region
between CDH2 and DSC3, pairs of 5’-biotinylated oligo-
nucleotides were obtained from IDT Inc. (Coralville, IA,
USA; Table S13 in Additional file 1). Equal volumes of
forward and reverse oligos (100 μM) were mixed and
heated at 95°C for 5 minutes and then cooled to room
temperature. Fifty femtomoles of annealed probes were
incubated at room temperature for 30 minutes with
10 mg SK-N-BE(2) nuclear extract (Active Motif Carlsbad,
CA, USA). The remaining steps followed the LightShift
Chemiluminescent EMSA Kit protocol (Thermo Scientific).
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The activity of a putative regulatory element and the
effect of SNP35 and SNP55 on gene expression were
examined by luciferase reporter assay. We PCR ampli-
fied an 879 bp-long orthologous sequence spanning
SNP35 and SNP55 from human DNA samples (Table
S14 in Additional file 1). The risk alleles were intro-
duced using a site-directed mutagenesis kit. The wild-
type and mutant DNA fragments were cloned into a firefly
luciferase reporter plasmid (pGL4.23, Promega Madison,
WI, USA). The test constructs were transiently co-
transfected with a Renilla luciferase reporter plasmid
(pGL4.73, Promega) as an internal control into neuro-
blastoma SK-N-BE(2) cells. All constructs were tested in
triplicates and repeated three times in a double-blinded
manner.
Cell cultures
Human SK-N-BE(2) cells were purchased from ATCC.
The cells were maintained at 37°C and 5% CO2 in 1:1
mixture of ATCC-formulated Eagle’s Minimum Essential
Medium (EMEM) and F-12 K medium supplemented
with 10% fetal bovine serum, 100 units/ml penicillin and
100 μg/ml streptomycin.
Real-time qPCR
Real-time qPCR was performed using Quantifast SYBR
Green PCR kit (QIAGEN, Hilden, Germany) on a Light-
cycler 480 system (Roche Applied Science, Indianapolis,
IN, USA). The reaction volumes were adjusted to 10 μl
with 3 μl of DNA (10 ng), 1 μl of both primers (10 μM)
and 5 μl of Master Mix. The qPCR program was as fol-
lows: pre-incubation at 95°C for 5 minutes, followed by
40 cycles of two-step amplification (10 s at 95°C, 1 mi-
nute at 60°C). All the experiments were carried out in
triplicates and include negative control without DNA.
The primer sets used to detect PGCP deletion is shown
in Table S15 in Additional file 1.
Data availability
The data presented in this publication are available
through the NCBI Sequence Read Archive (SRP033723)
and Gene Expression Omnibus (accession numbers
GSE53488 and GSE53577). Datasets analyzed in the
paper are also available at [67].
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Additional file 1: Texts S1 and S2, Tables S1 to S15, and Figures S1
to S6.
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